Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 29, 2018

Kent Imaging collaborates with SerenaGroup to improve wound care

Canadian medical technology company Kent Imaging has partnered with US-based wound healing research firm SerenaGroup to enhance wound tissue analysis by using near infrared imaging technology on its non-invasive KD203 device.

Canadian medical technology company Kent Imaging has partnered with US-based wound healing research firm SerenaGroup to enhance wound tissue analysis by using near infrared imaging technology on its non-invasive KD203 device.

Kent’s hand-held, portable device is a tissue oxygenation measurement system designed to assess oxygen saturation (StO2), relative oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) levels in superficial tissue.

“As part of the collaboration, SerenaGroup will use Kent’s technology as the standard of care for the assessment of wound oxygenation.”

The imaging technology delivers 2D colour-coded images that offer the information necessary for clinicians to identify at-risk tissue.

These insights can also help in treatment decisions and optimise patient outcomes in wound care, plastic surgery and other reconstructive applications.

As part of the collaboration, SerenaGroup will use Kent’s technology as the standard of care for the assessment of wound oxygenation.

The technology will be integrated into the SerenaGroup facilities and used in future clinical and preclinical research.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

SerenaGroup founder and medical director Dr Serena said: “One of the most troublesome and elusive criteria in treating wounds is the timely and accurate assessment of viable tissue.

“Kent’s device will propel us a long way down the healing path with a technology that has been lacking across the board in the Wound Care space.”

To date, SerenaGroup is said to have conducted more than 100 wound healing clinic trials.

Kent Imaging CEO Pierre Lemire said: “Our joint belief is that we can improve patient care and outcomes by significantly improving clinically relevant data that is required to assess and manage wounds.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU